Chromogranin A (CgA) in adrenal tumours.

CONCLUSION: In differential diagnosis of adrenal tumours, non-increased CgA level might be useful initial screening evidence for the exclusion of pheochromocytoma.(Endokrynol Pol 2013; 64 (5): 358-362). PMID: 24186592 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/24186592?dopt=Abstract

Source: Endokrynologia Polska - November 6, 2013 Category: Endocrinology Authors: Glinicki P, Jeske W, Bednarek-Papierska L, Kasperlik-Załuska A, Rosłonowska E, Gietka-Czernel M, Zgliczyński W Tags: Endokrynol Pol Source Type: research